This is what's known as a "functional" deficiency
Its worth noting, though, that shared search interest doesnt reflect a validated combination protocol
Based on these data, the FDA approved tesamorelin (marketed as EGRIFTA) for the reduction of excess abdominal fat in HIVassociated lipodystrophy, not as a general weightloss drug for the wider population. Tesamorelin Risks and Considerations Like all hormonemodulating therapies, tesamorelin carries potential risks, including fluid retention, joint pain, injectionsite reactions, and effects on glucose metabolism in susceptible patients
Seek urgent care for trouble breathing, facial or throat swelling, severe rash, chest tightness, or fainting
However, they interact with some drugs and should not be taken together
Personalized Treatment Plan Your healthcare provider explains whether vitamin B12 injections are appropriate and how often they may be needed